Merck Covid Pill

• Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home use

  Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce COVID-19 hospitalizations and deaths by around 30 per cent.

  World

  Dec 23, 2021
  
• U.K. banking on COVID-19 pills to get through winter amid Omicron surge

  Whether such drugs could be used to protect people from becoming ill after being exposed to a COVID-19 positive case is another possibility scientists are keen to explore.

  Health

  Dec 16, 2021
  
• Advertisement
• Merck to make its COVID-19 antiviral pill in Canada, company announces

  Merck has reached an agreement with an Ontario pharmaceutical company to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

  Health

  Dec 6, 2021
• Advertisement
• Canada secures orders of Merck, Pfizer COVID-19 antiviral pills

  Canada has announced it has signed purchasing agreements with Pfizer and Merck for their COVID-19 antiviral pills designed to treat the virus.

  Health

  Dec 3, 2021
• FDA panel backs Merck’s COVID-19 pill, company touts effectiveness against variants

  The Food and Drug Administration panel voted 13-10 that the antiviral drug's benefits outweigh its risks, including potential birth defects if used during pregnancy.

  Health

  Nov 30, 2021
• COVID-19 antiviral pill approved in U.K. still being reviewed by Health Canada

  Merck has been supplying data to Health Canada on a rolling basis since August, when the product was still undergoing clinical trials.

  Canada

  Nov 4, 2021
• COVID-19 pill developers aim to rival Pfizer, Merck treatments

  Infectious disease experts stressed that preventing COVID-19 through wide use of vaccines remains the best way to control the pandemic.

  Health

  Sep 28, 2021